Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1901-1906
Published online before print May 18, 2006, doi: 10.1161/01.ATV.0000227510.36653.ed
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
26/8/1901    most recent
01.ATV.0000227510.36653.edv1
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kreuz, W.
Right arrow Articles by Nowak-Göttl, U.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kreuz, W.
Right arrow Articles by Nowak-Göttl, U.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 2006;26:1901.)
© 2006 American Heart Association, Inc.


Thrombosis

Familial Elevated Factor VIII in Children With Symptomatic Venous Thrombosis and Post-Thrombotic Syndrome

Results of a Multicenter Study

Wolfhart Kreuz; Monika Stoll; Ralf Junker; Achim Heinecke; Rosemarie Schobess; Karin Kurnik; Reinhard Kelsch; Ulrike Nowak-Göttl

From the Department of Paediatric Haematology, Oncology, and Haemostaseology (W.K.), University Children’s Hospital, Frankfurt/Main; the Leibniz Institute for Arteriosclerosis Research, Department of Genetic Epidemiology (M.S.), University of Münster; the Institute of Clinical Chemistry and Laboratory Medicine (R.J.), University of Münster; the Coordination Centre for Clinical Trials (A.H.), University Hospital, Münster; the Department of Paediatrics (R.S.), University Children’s Hospital, Halle; the Department of Paediatrics (K.K.), University Children’s Hospital, Munich; the Department of Blood Transfusion Medicine (R.K.), University of Münster; and the Department of Paediatric Haematology/Oncology (U.N.-G.), University Children’s Hospital, Münster, Germany.

Correspondence to U. Nowak-Göttl, University Children’s Hospital, Paediatric Haematology and Oncology, Albert-Schweitzer-Str. 33, 48149 Münster, Germany. E-mail leagottl{at}uni-muenster.de

Objective— To evaluate the role of factor (F) VIII in children with non-cancer related venous thrombosis (DVT), post-thrombotic syndrome (PTS) or recurrent DVT.

Methods and Results— FVIII levels were measured in White patients and age- and gender-matched healthy controls. Heritability of factor VIII was estimated in 99 pedigrees by the variance component method implemented in SOLAR. The group of 103 patients showed higher median values of FVIII than 206 controls [FVIII:Ag, 115 versus 96 IU/dL, P<0.0001; FVIII:C, 119 versus 106 IU/dL, P=0.0009], and had a significantly increased odds ratio (OR) for fibrinogen-adjusted elevated FVIII levels [FVIII >90th percentile versus values below the cut-off: FVIII:Ag, OR 4.3, 95% confidence interval (CI) 1.5 to 12.1; FVIII:C, OR 5.5, CI 2.03 to 15.06]. PTS occurred in 19 of 59 children and persisted in 5 individuals. Recurrent DVT was seen in 8 patients. The heritable(h2)/household(c2) components were calculated for FVIII:Ag levels (h2, 0.48±0.15, P=0.0008; c2, 0.21), and FVIII:C (h2, 0.61±0.15, P<0.0001; c2, 0.41). When incorporating h2 and c2 in the estimate, the phenotypic variance for FVIII:Ag levels is predominantly explained by h2, whereas c2 stayed significant in the model for FVIII:C (P=0.00002).

Conclusions— Elevated FVIII levels increase the DVT-risk in children.

Case–control study measuring FVIII in children experiencing DVT. FVIII values were elevated in patients. The odds ratio for FVIII above the 90th percentile was increased in DVT patients. The heritable(h2)/household(c2) components were calculated for FVIII:Ag levels (h2, 0.48±0.15; c2, 0.21), and FVIII:C (h2, 0.61±0.15; c2, 0.41).


Key Words: factor VIII and children • body mass index • venous thrombosis • post-thrombotic syndrome • recurrent thrombosis




This article has been cited by other articles:


Home page
BloodHome page
U. Nowak-Gottl, B. Frohlich, S. Thedieck, A. Huge, and M. Stoll
Association of the protein Z ATG haplotype with symptomatic nonvascular stroke or thromboembolism in white children: a family-based cohort study
Blood, March 5, 2009; 113(10): 2336 - 2341.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
G. Young, M. Albisetti, M. Bonduel, L. Brandao, A. Chan, F. Friedrichs, N. A. Goldenberg, E. Grabowski, C. Heller, J. Journeycake, et al.
Impact of Inherited Thrombophilia on Venous Thromboembolism in Children: A Systematic Review and Meta-Analysis of Observational Studies
Circulation, September 23, 2008; 118(13): 1373 - 1382.
[Abstract] [Full Text] [PDF]


Home page
ASH Education BookHome page
N. A. Goldenberg
Thrombophilia States and Markers of Coagulation Activation in the Prediction of Pediatric Venous Thromboembolic Outcomes: A Comparative Analysis with Respect to Adult Evidence
Hematology, January 1, 2008; 2008(1): 236 - 244.
[Abstract] [Full Text] [PDF]


Home page
BloodHome page
K. R. Viel, D. K. Machiah, D. M. Warren, M. Khachidze, A. Buil, K. Fernstrom, J. C. Souto, J. M. Peralta, T. Smith, J. Blangero, et al.
A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels
Blood, May 1, 2007; 109(9): 3713 - 3724.
[Abstract] [Full Text] [PDF]